Naor Gilon, Ambassador of Israel to India, inaugurated and dedicated India’s first MRgFUS Technology to the nation in the presence of Dr Madeswaran, Chairman and Managing Director, Royal Care Super Speciality Hospital, and other dignitaries in the city recently.
Royal Care Super Speciality Hospital, Coimbatore has set up India’s First MRgFUS (Magnetic Resonance Guided Focused Ultrasound Surgery) – a new technology for the treatment of Essential Tremors and Tremor Dominant Parkinson’s disease and has the potential to change the way movement disorders.
For the treatment of essential tremors and tremor-dominant Parkinson’s disease MRgFUS is approved by the Central Drugs Standard Control Organization (CDSCO) which is a part of the Ministry of Health and Family Welfare of India. MRgFUS has also been approved by the US Food and Drug Administration (USFDA).
Dr Madeswaran, said, “This treatment procedure is conducted by a team of highly qualified and experienced neurosurgeons and neurologists who have been specifically trained in the focused ultrasound technique to target sub-millimetre areas in the brain.”
MRgFUS works under the principle of combining 2 technologies – Magnetic Resonance Imaging aids and Ultrasound. At present, MRgFUS has been approved for the treatment of Essential Tremor and Tremor Dominant Parkinson’s disease in India. Many patients have reported an immediate improvement in tremors with minimal temporary complications. Over 3500 patients have been treated to date around the world.